# 1160P Efficacy and biomarker identification of neoadjuvant chemo-immunotherapy in potentially resectable non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/1160p-efficacy-and-biomarker-identification-of-neoadjuvant-chemo-immunotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Y. Zhang,L. Zeng,X. Zhang,Yumin Zhou,Bei Zhang,Lin Guo,Y. Guan,Xiang Gao,H. Wang,Xiuwen Xia,Caicun Zhou,Ning Yang |
| Citations | 7 |
| DOI | 10.1016/j.annonc.2021.08.1763 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3203508266 |
| Type | article |
| Year | 2021 |

## Paper authors

- [L. Zeng](https://scholariq.org/researchers/l-zeng/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.